WA
TMO icon

WESPAC Advisors’s Thermo Fisher Scientific TMO Stock Holding History

WESPAC Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,920
Closed -$1.12M – 182
2024
Q1 		$1.12M Buy
1,920
+933
+95% +$524K 0.65% 52
2023
Q4 		$524K Sell
987
-37
-4% -$17.9K 0.36% 88
2023
Q3 		$518K Buy
1,024
+48
+5% +$25.6K 0.39% 85
2023
Q2 		$509K Sell
976
-62
-6% -$33.5K 0.41% 74
2023
Q1 		$598K Sell
1,038
-292
-22% -$165K 0.56% 59
2022
Q4 		$733K Sell
1,330
-211
-14% -$112K 1.27% 27
2022
Q3 		$782K Buy
1,541
+796
+107% +$445K 1.05% 36
2022
Q2 		$405K Buy
+745
New +$410K 0.31% 64
2022
Q1 		– Sell
-335
Closed -$224K – 152
2021
Q4 		$224K Buy
+335
New +$209K 0.15% 137
2021
Q1 		– Sell
-1,069
Closed -$498K – 186
2020
Q4 		$498K Buy
+1,069
New +$501K 0.38% 82
2014
Q2 		– Sell
-21,338
Closed -$2.57M – 134
2014
Q1 		$2.57M Buy
21,338
+146
+0.7% +$17.4K 2.22% 5
2013
Q4 		$2.36M Buy
21,192
+2,349
+12% +$234K 1.96% 4
2013
Q3 		$1.74M Buy
18,843
+808
+4% +$73.1K 2.02% 6
2013
Q2 		$1.53M Buy
+18,035
New +$1.5M 2.32% 5

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WESPAC Advisors's TMO Position: Q2 2024 in Review

WESPAC Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 1,920 shares — an estimated $1.12M sold.

WESPAC Advisors first reported a position in TMO in Q2 2013 and held it in 14 quarters. The position peaked at $2.57M in Q1 2014. 2,543 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • WESPAC Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
  • WESPAC Advisors sold 1,920 Thermo Fisher Scientific shares in Q2 2024, an estimated $1.12M.
  • WESPAC Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 14 quarters.
  • WESPAC Advisors's Thermo Fisher Scientific position peaked at $2.57M in Q1 2014.
  • 2,543 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on WESPAC Advisors's 13F filing for Q2 2024, filed 30 Jul 2024.